Bryan Beardsley, MD
Orthopaedic Surgery · Lewiston, IDNPI 1104856087
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (47.2%), food and beverage and education — rather than concentrated in one kind of arrangement. Stryker accounts for 73.1% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $4,355 and has fallen 97.2% since, to $124 in 2025.
Across 67 payments — averaging $98.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$5K
- Summit Surgical Corp.$1K
- Smith+Nephew$273
- Ferring Pharmaceuticals Inc.$64
- Pacira Pharmaceuticals Incorporated$46
- FX Shoulder Solutions, Inc$44
- plus $100 from 5 others
What the payments were for
- Travel & lodging$3,10047%
- Food & beverage$2,26735%
- Education$1,20018%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 49 | $4,800 |
| Summit Surgical Corp. | 3 | $1,240 |
| Smith+Nephew | 4 | $273 |
| Ferring Pharmaceuticals Inc. | 3 | $64 |
| Pacira Pharmaceuticals Incorporated | 1 | $46 |
| FX Shoulder Solutions, Inc | 1 | $44 |
| Heron Therapeutics, Inc. | 2 | $37 |
| Johnson & Johnson | 1 | $18 |
| Bioventus LLC | 1 | $17 |
| Merck | 1 | $14 |
| Molnlycke Health Care US, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$3,777
- MOTIONSENSE DIGITAL GONIOMETER$1,541
- TRIATHLON$1,541
- INSIGNIA$1,541
How this compares
$6,567 in reported general payments places this provider in the 55th percentile of 139 orthopaedic surgery providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 68 | $627 |
| Meloxicam | 81 | $273 |
| Oxycodone Hcl | 18 | $208 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 19 | $182 |
| Methylprednisolone | 26 | $128 |
| Tramadol Hcl | 18 | $71 |
| Promethazine Hcl | 22 | $48 |
| Amoxicillin | 12 | $13 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Lewiston
- Regan HansenLewiston$41K
- Caleb NettingLewiston$15K
- Carl HumphreyEagle$9.4M
- Richard MooreBoise$7.4M
- Roman SchwartsmanBoise$358K
- Lucas AndersonCoeur D Alene$243K
- Jeffry MenznerBoise$194K
- Justin DazleyTwin Falls$184K
- Christopher HiroseBoise$182K
- Joseph LynchBoise$140K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.